Atossa Therapeutics financial statements
아토사 테라퓨틱스NASDAQ:ATOS · Nasdaq · Healthcare$2.45+4.70%
2026-10-05 close · prelimAtossa Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$29M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy